Treatment with broadly neutralizing influenza antibodies reduces severity of secondary pneumococcal pneumonia in mice

@inproceedings{Grve2018TreatmentWB,
  title={Treatment with broadly neutralizing influenza antibodies reduces severity of secondary pneumococcal pneumonia in mice},
  author={Frank van Someren Gr{\'e}ve and Koenraad F. van der Sluijs and Anita M Tuip and Marcus J. Schultz and Menno D. T. de Jong and Nicole P Juffermans},
  booktitle={Journal of medical virology},
  year={2018}
}
Secondary bacterial pneumonia is a frequent complication of influenza, associated with high morbidity and mortality. We hypothesized that treatment with neutralizing influenza A antibody AT10_002 protects against severe secondary pneumococcal infection in a mouse model of influenza A infection. Influenza A (H3N2) virus-infected male C57Bl6 mice were treated… CONTINUE READING